Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesEffects of Olanzapine and Risperidone on Metabolic Factors in Children and Adolescents: A Retrospective Evaluation
Journal of Psychiatric Practice, 07/28/09
- The study was a retrospective chart review of hospitalized patients younger than olanzapine or risperidone Data collected from medical charts were analyzed to assess weight gain, lipid profiles, blood pressure, and glucose levels in patients prescribed olanzapine or risperidone.
- A total of 49 patients (25 receiving olanzapine and 24 receiving risperidone) with a mean age of 13 years were included in the study; the mean duration of treatment was 27 days.
- A significant increase in body mass index (BMI) from baseline to endpoint in both treatment groups was found (P<0.001); however, the change in BMI was not significantly different between the olanzapine and risperidone groups (P=0.425).
- Seven new cases (28%) in the olanzapine group and 4 new cases (17%) in the risperidone group met criteria for being overweight or at risk for being overweight.
- A significant increase in mean systolic blood pressure was found in subjects receiving olanzapine compared with those receiving risperidone (+5.4 mm Hg vs. -3.2 mm Hg; P=0.044), while diastolic blood pressure did not differ between the treatment groups.
- A significant increase in risk factors for diabetes mellitus (P=0.008) and in overall risk factors for metabolic syndrome (P=0.013) was found in the olanzapine group over the course of treatment, whereas no significant effect on risk factors for diabetes or metabolic syndrome was found in the risperidone group.
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
Journal of Psychopharmacology, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09
Quetiapine treatment and improved cognitive functioning in borderline personality disorder
Human Psychopharmacology: Clinical and Experimental, 12/04/09
Today in Psychotherapy/analysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Correlates of Long-term Posttraumatic Stress Symptoms in Children Following Hurricane Katrina
Child Psychiatry and Human Development, 12/07/09
Are psychological treatments effective for fibromyalgia pain?
Current Rheumatology Reports, 12/04/09
Cognitive-behavioral therapy for sleep abnormalities of chronic pain patients
Current Rheumatology Reports, 12/04/09
Sponsor
Article Search
Sponsor